Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/15/2007CN101015675A Massage washing lotion
08/15/2007CN101015674A Car sickness preventing and treating beverage
08/15/2007CN101015666A Medicine composition for treating hepatic disease
08/15/2007CN101015653A Health care medicinal liquor
08/15/2007CN101015648A Use of succinic acid derivative eater compound for treating dementia
08/15/2007CN101015642A Compound capsule for decreasing alcohol and protecting liver
08/15/2007CN101015639A 红色烧伤膏 Red burn ointment
08/15/2007CN101015627A Medicine composition for treating diabetes and its preparation
08/15/2007CN101015625A Traditional Chinese medicine for preventing and treating chilblain
08/15/2007CN101015598A Externally used pharmaceutical preparation for treating disease caused by acarids
08/15/2007CN101015592A Compound Chinese medicine preparation of breviscapine
08/15/2007CN101015586A Traditional Chinese medicine powder for treating tinea pedis and foot sweat
08/15/2007CN101015585A Medicine composition for dispelling speckle and whitening skin
08/15/2007CN101015579A Medicament for treating trauma ulcer
08/15/2007CN101015576A Medicine for preventing and treating cardiovascular and cerebrovascular diseases by increasing hypoxia-resistant ability and its preparing method
08/15/2007CN101015571A Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process
08/15/2007CN101015570A Children's health food of probiotics and its production process
08/15/2007CN101015568A Dermatophytosis treating medicine
08/15/2007CN101015567A Medicine composition for treating ophthalmological diseases and preparing process thereof
08/15/2007CN101015566A Combined treatment method for type 2 diabetes by using camel milk and rosiglitazone maleate
08/15/2007CN101015564A Exterior-applied pigmentum for treating otitis media suppurativa and its preparing method
08/15/2007CN101015563A Intravenous injection microemulsion preparation of teniposide
08/15/2007CN101015562A DiAo Xinxuekang soft capsule and preparation process and use thereof
08/15/2007CN101015561A Compound genticin-micronomicin injection, preparing method and use thereof
08/15/2007CN101015560A Compound suladime sulfadiazine sodium injection and its preparation
08/15/2007CN101015559A Instant gelling agent for treating allergic rhinitis
08/15/2007CN101015558A Preparation of superfine prednisolone powder
08/15/2007CN101015557A Combination of an inhibitor of the if current of the sinus node and an inhibitor of the angiotensin converting enzyme, and pharmaceutical ingredients containing said association
08/15/2007CN101015556A New association of an if sinusoidal current inhibitor and a calcium channel-blocking agent, and pharmaceutical ingredients containing said association
08/15/2007CN101015555A Inclusion compound of lornoxicam and hydroxypropyl-beta-cyclodextrin and its preparation method
08/15/2007CN101015554A 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-benzamide for treating pulmonary fibrosis
08/15/2007CN101015553A Medicinal composition for treating skin superficial fungal infection and preparation process thereof
08/15/2007CN101015552A Ligustilide extract and its preparing process and application
08/15/2007CN101015551A Preparing method of triptolide stereoscopic stable liposome nano granule
08/15/2007CN101015550A Preparing method of triptolide molecule microcapsule
08/15/2007CN101015549A Preparing and detecting method of triptolide liposome nano granule
08/15/2007CN101015548A Compound paclitaxel preparation containing phospholipid dispersant and its preparation method
08/15/2007CN101015547A Docetaxel liposome formulation and preparation method thereof
08/15/2007CN101015546A Verapamil formulation absorbed by oral or nasal mucous membrane
08/15/2007CN101015545A Use of phenylpropionic acid and phenyl propyl compound with oxidation resistance function for protecting liver and brain damage
08/15/2007CN101015544A Use of phenyl propyl compound with oxidation resistance function for protecting liver and brain damage
08/15/2007CN101015543A Use of cinnamic acid and allyl benzoate compound with oxidation resistance function for protecting liver and brain damage
08/15/2007CN101015542A Compound paracetamol injection for livestock and process for preparing same
08/15/2007CN101015541A Diacetyl rhein dropping pills and its preparing process
08/15/2007CN101015540A Refreshing eyedrop and its preparation
08/15/2007CN101015539A Preparation of nedaplatin freeze-dried powder injection
08/15/2007CN101015538A Medicinal composition of total capsicine compounds and beta-cyclodextrin or derivative of beta-cyclodextrin
08/15/2007CN101015537A Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule
08/15/2007CN101015536A Sustained release preparation containing cilostazol and its preparation method
08/15/2007CN101015535A Sustained release preparation of perhexiline
08/15/2007CN101015534A Sustained release preparation of phenprobamate
08/15/2007CN101015533A Sustained release preparation of norfloxacin
08/15/2007CN101015532A Sustained release preparation of phenytoin sodiumslow release
08/15/2007CN101015531A Sustained release preparation of dibazole
08/15/2007CN101015530A Sustained release preparation of doxepin
08/15/2007CN101015529A Sustained release preparation of amoxillin and dicloxacillin
08/15/2007CN101015528A Sustained release preparation of amoxillin and flucloxacillin
08/15/2007CN101015526A Topotecan liposome and preparation method therefor
08/15/2007CN101015525A Paclitaxel liposome and preparation method therefor
08/15/2007CN101015524A Coenzyme Q10 oral emulsion and preparing process thereof
08/15/2007CN101015523A Compound sarafloxacin hydrochloride injection, preparing method and use thereof
08/15/2007CN101015522A Cream for treating psoriasis and its preparing process
08/15/2007CN101015520A Alendronate pharmaceutical composition and its prepn. technique
08/15/2007CN101015519A Loratadine oral compound medication composition
08/15/2007CN101015518A Balsalazide sodium enteroclyster and its preparing method
08/15/2007CN101015501A Injection composition of fat milk, amino acid and glucose packed with three-cavity bag and preparing method thereof
08/15/2007CN101015485A Self-heating medical treatment apparatus for treating cervical spondylosis and lumbar spondylosis co-operating with Chinese medicine soup
08/15/2007CN101015350A Senescence delaying health care composition
08/15/2007CN101015342A Preparation method of lycopersicin microcapsule
08/14/2007US7256310 L-tartrate derivative; stable particle size distribution; reproducible dosing; can be stored under varying temperature and humidity conditions
08/14/2007US7256307 Substituted phenypropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor α(PPAR)
08/14/2007US7256287 small molecule inhibitors of the IgE response to allergens that are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic
08/14/2007US7256267 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01
08/14/2007US7256263 High molecular weight Dermatophagoides proteins, and nucleic acids encoding them; used to treat and diagnose mite allergies
08/14/2007US7256219 Multifluoro-substituted chalcones and analogs as activators of caspases and inducers of apoptosis and the use thereof
08/14/2007US7256218 Biguanide and dihydrotriazine derivatives
08/14/2007US7256217 Prodrugs of excitatory amino acids
08/14/2007US7256216 Powder mixture of aminobutyric acid and solid polyol; therapy for brain disorders; central nervous system disorders; analgesics; headaches
08/14/2007US7256215 Crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
08/14/2007US7256214 5,7,3',4'-Tetrahydroxy-5'-C-geranylflavanone (isonymphaeol-B), isolated from an Okinawa propolis; microbiocide, antitumor agent, food, beverage and cosmetic preservative; antioxidant food supplement
08/14/2007US7256213 Taxanes having a C10 carbonate substituent
08/14/2007US7256212 Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
08/14/2007US7256211 Containing a carboxy-substituted thiazolylthio group, e.g., 15 alpha ,13E)-9-oxo-15-hydroxy-16-(4-fluoro-3-phenylphenyl)-5-(4-carboxythiazol-2-yl)-1,2,3,4,17,18,19,20-octanol-5-thia-8-azaprost-13-ene; EP4 agonistic action and are useful for treating diseases including immunological disorders and asthma
08/14/2007US7256210 7-amido-isoindolyl compounds and methods of their use
08/14/2007US7256209 Pyrazole derivatives and diabetic medicine containing them
08/14/2007US7256208 Monocyclic N-Aryl hydantoin modulators of androgen receptor function
08/14/2007US7256207 Inhibitors of cathepsin S
08/14/2007US7256206 1-[4-(3-Amino-4-hydroxy-3-hydroxymethyl-butyl)-phenyl]-ethanone-O-biphenyl-4-ylmethyl-oxime, used as modulators of lipid activated G-protein coupled receptors specific for sphingosine-1-phosphate; prevention of autoimmune diseases or as angiogenesis inhibitors
08/14/2007US7256205 2-Aminothiazole histamine H2 receptor antagonists such as famotidine or nizatidine to which is linked at least one NO and/or NO2 group; treating inflammations including gastrointestinal disorders and reducing the gastrointestinal toxicity associated with the use of NSAIDS
08/14/2007US7256204 6-(4-biphenylyl)methoxy-2-(2-(N,N-dimethylamino)ethyl)tetralin for example; inhibiting amyloid-beta protein production; for neurodegenerative diseases such as Alzheimer's disease
08/14/2007US7256203 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents
08/14/2007US7256202 Treating hyperammonemia by orally administering a composition free of serum electrolytes and containing 0.15 to 3.5 parts by weight polyethylene glycol to 1 part by weight lactulose to reduce plasma ammonia to acceptable levels
08/14/2007US7256201 Selective estrogen receptor-β ligands
08/14/2007US7256200 administering mixture of opioid and calmodulin kinase inhbitor
08/14/2007US7256199 2-(Substituted amino)-6-(4-pyridyl)pyrimidin-4-ones, e.g., 2-(N-phenylamino)-6-(4-pyridyl)pyrimidin-4-one and 2-(N-(3-bromophenyl)amino)-6-(4-pyridyl)pyrimidin-4-one; treatment of diseases caused by tau protein kinase 1 hyperactivity such as Alzheimer disease.
08/14/2007US7256198 Pyrimidoindolones and methods for using same
08/14/2007US7256197 Methods for synthesis of diarylmethanes
08/14/2007US7256196 2-(Mono- or polyhalophenoxy- or anilino)-8,9-substituted purines, e.g., N-8-(2-Chlorophenyl)-9-methyl-N-2-(tetrahydro-pyran-4-yl)-9H-purine-2,8-diamine and [2-(2,6-Difluorophenoxy)-9-ethyl-9H-purin-8-yl]-(fluorophenyl)-amine
08/14/2007US7256194 Compounds that inhibit factor Xa activity
08/14/2007US7256193 Therapeutic agents useful for treating pain
1 ... 3629 3630 3631 3632 3633 3634 3635 3636 3637 3638 3639 3640 3641 3642 3643 3644 3645 3646 3647 3648 3649 ... 7860